Boston Partners Grows Stock Position in Humana Inc. (NYSE:HUM)

Boston Partners raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 435.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,098,702 shares of the insurance provider's stock after buying an additional 893,637 shares during the period. Boston Partners owned about 0.91% of Humana worth $279,236,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Transcend Capital Advisors LLC boosted its stake in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after purchasing an additional 2,914 shares during the period. FNY Investment Advisers LLC increased its position in shares of Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock worth $6,916,000 after acquiring an additional 26,856 shares during the period. Retirement Systems of Alabama raised its stake in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares during the period. Finally, PDT Partners LLC grew its stake in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock worth $1,286,000 after purchasing an additional 2,660 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Remove Ads

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.37% of the stock is owned by company insiders.

Analysts Set New Price Targets

HUM has been the topic of a number of recent research reports. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Barclays increased their target price on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th. Truist Financial upped their price target on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $285.68.

Humana Price Performance

Shares of Humana stock traded down $0.50 during trading hours on Friday, reaching $266.33. The stock had a trading volume of 1,963,596 shares, compared to its average volume of 1,716,116. The stock's 50 day moving average is $271.33 and its 200 day moving average is $276.92. The firm has a market capitalization of $32.14 billion, a PE ratio of 26.77, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.